Notícias Forex

AbbVie Announces Topline Results From Phase 2 LUMINOSITY Trial Of Telisotuzumab-Vedotin

Biopharmaceutical company AbbVie, Inc. (ABBV) announced Wednesday topline results from the single-arm Phase 2 LUMINOSITY trial evaluating telisotuzumab-vedotin (Teliso-V) in patients with c-Met protein overexpression, epidermal growth factor receptor (EGFR) wild type, advanced/metastatic nonsquamous non-small cell lung cancer (NSCLC). The trial demonstrated compelling clinical benefits across key endpoints.
RTTNews | 561 dias atrás
Philips' Stock Hit By FDA Warning Against DreamStation 2 CPAP Machines

Philips' Stock Hit By FDA Warning Against DreamStation 2 CPAP Machines

Shares of Philips Electronics NV were losing around 5 percent in Amsterdam trading as well as in the pre-market activity on the NYSE after the U.S. regulator warned against the safety of Dutch consumer electronics giant's DreamStation 2 Continuous Positive Airway Pressure or CPAP Machines. The Food and Drug Administration or FDA said it is alerting patients and healthcare providers of an emerging
RTTNews | 561 dias atrás
U.S. GDP Jumps More Than Previously Estimated In Q3

U.S. GDP Jumps More Than Previously Estimated In Q3

Revised data released by the Commerce Department on Wednesday showed the U.S. economy grew faster than previously estimated in the third quarter of 2023. The Commerce Department said the jump by real gross domestic product in the third quarter was upwardly revised to 5.2 percent from the previously reported 4.9 percent.
RTTNews | 561 dias atrás
UK Mortgage Approvals Hit 3-Month High

UK Mortgage Approvals Hit 3-Month High

UK mortgage approvals increased more than expected to a three-month high in October signaling a slowdown in the housing market downturn after the central bank kept interest rates unchanged in September and November. Net mortgage approvals for house purchases rose to a three-month high of 47,400 in October from 43,700 in September, the Bank of England reported Wednesday.
RTTNews | 561 dias atrás
Okta Boosts FY24 Outlook As Q3 Results Top Estimates

Okta Boosts FY24 Outlook As Q3 Results Top Estimates

Independent identity partner Okta, Inc. (OKTA) reported Wednesday a net loss for the third quarter of $81 million or $0.49 per share, sharply narrower than $209 million or $1.32 per share in the prior-year quarter.
RTTNews | 561 dias atrás
more news
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Canadian shares are likely to open higher on Wednesday, tracking positive European stocks, and higher crude oil prices. Optimism about interest rate cuts from the first quarter of 2024 is also likely to support the market.
RTTNews | 561 dias atrás
Eurozone Economic Confidence Logs Moderate Rise

Eurozone Economic Confidence Logs Moderate Rise

Eurozone economic confidence improved moderately in November, thanks to higher sentiment among consumers and construction managers, survey results from the European Commission revealed Wednesday. The economic confidence index rose to 93.8 in November from 93.5 in October. The reading came in line with expectations.
RTTNews | 561 dias atrás
Patterson Trims FY24 Outlook - Update

Patterson Trims FY24 Outlook - Update

While reporting financial results for the second quarter on Wednesday, medical supplies company Patterson Companies Inc. (PDCO) trimmed its earnings and adjusted earnings guidance for the full-year 2024.
RTTNews | 561 dias atrás
Dollar Tree Trims FY23 Earnings, Revenue Outlook - Update

Dollar Tree Trims FY23 Earnings, Revenue Outlook - Update

While reporting financial results for the third quarter on Wednesday, Dollar Tree, Inc. (DLTR) provided guidance for the fourth quarter and trimmed its earnings and revenue guidance for the full-year 2023.
RTTNews | 561 dias atrás

Stay up to date!

Add Notícias to your browser

Extension Picture